# US 2008/0306149 A1 · Use for a Composition Comprising Chloroprocaine Hcl, a New Composition Comprising Chloroprocaine Hcl and a Method for Its Manufacture

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2008/0306149 A1
- Document ID: US20080306149A1
- Status: Published application
- Kind: A1
- Application number: 11/991,449
- Filed: 2006-09-05
- Published: 2008-12-11
- Earliest claimed: 2005-09-06
- Assignees: Sintetica S.A.
- Inventors: Augusto Mitidieri; Elisabetta Donati
- Web page: https://patentgrep.com/patent/US20080306149A1

## CPC

- A61K 31/245: Amino benzoic acid types, e.g. procaine, novocaine (salicylic acid esters A61K31/60)
- A61K 9/0019: {Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner (non-active ingredients are additionally classified in A61K47/00)}
- A61K 9/0085: {Brain, e.g. brain implants; Spinal cord}
- A61P 23/02: Local anaesthetics
- A61P 43/00: Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

The present invention concerns a new use for a composition comprising chloroprocaine HCl, and in particular its use for the manufacture of a drug for intrathecal narcosis. The present invention also concerns a new composition comprising chloroprocaine HCl, being particularly suited to this new use, as well as a new method for manufacturing said composition.

## Claims

### Claim at position 1

-19. (canceled)

### Claim 20

A method for intrathecal narcosis which comprises the step of administering to a subject in need thereof a preservative-free composition comprising chloroprocaine HCl in solution in water for injection.

### Claim 21 (depends on 20)

The method as claimed in claim 20, wherein the composition has a pH of 3.0-4.0.

### Claim 22 (depends on 20)

The method as claimed in claim 20, wherein the composition comprises: chloroprocaine HCl, sodium chloride, water for injections and hydrochloric acid.

### Claim 23 (depends on 22)

The method as claimed in claim 22, wherein the composition comprises, per ml of solution in water for injection: 9-11 mg chloroprocaine HCl, 6-8 mg NaCl, and HCl in a sufficient quantity to impart a pH of 3.0-4.0.

### Claim 24 (depends on 23)

The method as claimed in claim 23, wherein the composition has an osmolarity of between 270 and 300 mOsm/kg.

### Claim 25 (depends on 23)

The method as claimed in claim 23, wherein the composition has a relative density at 20° C. of between 1.0070 and 1.0080.

### Claim 26

The method for manufacturing a drug intended for intrathecal narcosis, characterized by using a preservative-free composition comprising chloroprocaine HCl in solution in water for injection.

### Claim 27 (depends on 26)

The method as claimed in claim 26, wherein the composition has a pH of 3.0-4.0.

### Claim 28 (depends on 26)

The method as claimed in claim 26, wherein the composition comprises: chloroprocaine HCl, sodium chloride, water for injection, and hydrochloric acid.

### Claim 29 (depends on 28)

The method as claimed in claim 28, wherein the composition comprises, per ml of solution in water for injection: 9-11 mg chloroprocaine HCl, 6-8 mg NaCl, and HCl in a sufficient quantity to impart a pH of 3.0-4.0.

### Claim 30 (depends on 29)

The method as claimed in claim 29, wherein the composition has an osmolarity of between 270 and 300 mOsm/kg.

### Claim 31 (depends on 29)

The method as claimed in claim 29, wherein the composition has a relative density at 20° C. of between 1.0070 and 1.0080.

### Claim 32

A pharmaceutical composition in the form of an aqueous solution comprising, per ml of solution in water for injection: 9.0-11 mg chloroprocaine HCl, 6-8 mg NaCl, and HCl in a sufficient quantity to impart a pH of 3.0-4.0.

### Claim 33 (depends on 32)

The composition as claimed in claim 32, wherein the composition has an osmolarity of between 270 and 300 mOsm/kg.

### Claim 34 (depends on 32)

The composition as claimed in claim 32, wherein the composition has a relative density at 20° C. of between 1.0070 and 1.0080.

### Claim 35 (depends on 32)

A method for obtaining a pharmaceutical composition as in claim 32, comprising the following steps:
mixing water for injection, chloroprocaine HCl, NaCl and HCl, in the necessary quantities, in an inert gas atmosphere to give a medicated solution under inert gas;
filtering the medicated solution through a sterilizing filter (0.22 μm);
dispensing the filtered medicated solution into vials under inert gas; and
sterilizing the filtered medicated solution in sealed vials under inert gas, at least 121° C. for at least 10 minutes (F0>10 minutes), to provide a sterilized medicated solution.

### Claim 36 (depends on 35)

The method as claimed in claim 35, wherein the inert gas is chosen from the group consisting of nitrogen and a rare gas.

### Claim 37 (depends on 35)

The method as claimed in claim 35, wherein the dispensing is done into 5 ml vials.

### Claim 38 (depends on 37)

The method as claimed in claim 37, wherein the vials are of dark glass, to protect the contents from light, or clear glass vials.
